Pharmacology

Pharmacology

药理

  • 4区 中科院分区
  • Q2 JCR分区

期刊简介

《Pharmacology》是由S. Karger AG出版社于1968年创办的英文国际期刊(ISSN: 0031-7012,E-ISSN: 1423-0313),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q2,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0210...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比82.98%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在47篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Pharmacology审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约47篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 47 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 147 / 354

58.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 149 / 354

58.05%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.6 SJR:0.679 SNIP:0.699
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q2 135 / 313

57%

期刊发文

  • LncRNA DDX11-AS1 Promotes Chemoresistance through LIN28A-Mediated ATG12 mRNA Stabilization in Breast Cancer

    Author: Si, Xinxin; Zhang, Gongming; Li, Mingyuan; Yao, Mingli; Shi, Xiao; Dong, Zibo; Gao, Song

    Journal: PHARMACOLOGY. 2023; Vol. 108, Issue 1, pp. 61-73. DOI: 10.1159/000527222

  • Astragaloside IV Alleviates Atorvastatin-Induced Hepatotoxicity via AMPK/SIRT1 Pathway

    Author: Qin, Lili; Wang, Yanxia; Liang, Yingying; Li, Qiang; Xie, Xuerong; Zhang, Honglian

    Journal: PHARMACOLOGY. 2023; Vol. 108, Issue 1, pp. 74-82. DOI: 10.1159/000527231

  • Luteolin Attenuates Diabetic Myocardial Hypertrophy by Inhibiting Proteasome Activity

    Author: Li, Xiao-bing; Rekep, Mubarak; Tian, Jia-hui; Wu, Qian; Chen, Mei; Yang, Shuo; Zhang, Lu-xuan; Zhang, Gui-ping; Qin, Yuan; Yu, Xi-yong; Xue, Qin; Liu, Ying-hua

    Journal: PHARMACOLOGY. 2023; Vol. 108, Issue 1, pp. 47-60. DOI: 10.1159/000527201

  • Protective Effects and Mechanisms of Flavonoids in Renal Ischemia-Reperfusion Injury

    Author: Peng, Peng; Zou, Junrong; Zhong, Bin; Zhang, Guoxi; Zou, Xiaofeng; Xie, Tianpeng

    Journal: PHARMACOLOGY. 2023; Vol. 108, Issue 1, pp. 27-36. DOI: 10.1159/000527262

  • Osimertinib in the Treatment of EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer: A Meta-Analysis

    Author: Pan, Jie; Cai, Xiaoping; Cao, Zhuo; Pan, Jiongwei; Zheng, Hao

    Journal: PHARMACOLOGY. 2023; Vol. 108, Issue 1, pp. 8-16. DOI: 10.1159/000527321

  • Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis

    Author: Li, Hong-Yan; Wang, Yong-Bo; Ren, Xiang-Ying; Wang, Jing; Wang, Hai-Shan; Jin, Ying-Hui

    Journal: PHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1159/000527668

  • DPP4 Inhibitor Sitagliptin Reduces Inflammatory Responses and Mast Cell Activation in Allergic Rhinitis

    Author: Sun, Xiuying; Xu, Yu; Zhou, Jinhui

    Journal: PHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1159/000528634

  • Research Progress on the Anticancer Molecular Mechanism of Targets Regulating Cell Autophagy

    Author: Zhang, Ting; Yu, Jia; Cheng, Sha; Zhang, Ya; Zhou, Chang-hua; Qin, Juan; Luo, Heng

    Journal: PHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1159/000529279